Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,962 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07693998Enrolling by invitation
Pain education class for fibromyalgia or chronic back pain
This trial tests a class to help people with fibromyalgia or chronic low back pain learn about their pain and how to manage it. It might help you feel better and understand your pain.
Valencia, ValenciaAges 18 years+ - NCT06487546Recruiting
Ergothioneine supplement study for dialysis patients
This study tests whether giving a natural antioxidant called ergothioneine can help people with kidney failure who are on dialysis. It aims to see if it improves their health or well-being.
Palo Alto, CaliforniaAges 18 years+ - NCT06487832Recruiting
Effect of diabetes drug on brain response to insulin
This study tests whether a GLP-1 receptor agonist (a type of diabetes medicine) changes how the brain responds to insulin in people with different body sizes. It may help understand if this drug can improve brain function related to insulin.
TübingenAges 18–70 - NCT06488781RecruitingPhase 2
Antibiotics before labor induction for first-time moms with obesity
This study tests whether giving a single antibiotic (azithromycin) before labor induction can help prevent complications in first-time mothers who have obesity. It aims to make delivery safer for you and your baby.
Oklahoma City, OklahomaAges 15–45 - NCT06489587Recruiting
Creatine at simulated altitude for active adults
This study tests if taking creatine supplements helps active adults during exercise in simulated high-altitude conditions. It may help you understand how your body performs with creatine in low-oxygen environments.
San Luis Obispo, CaliforniaAges 18–40 - NCT06489873Recruiting
Lutein, Zeaxanthin, and Fish Oil for Macular Health
This study tests whether taking daily supplements of lutein, zeaxanthin, and fish oil can improve the protective pigment in your eyes. It may help people with low macular pigment and good vision who are not already taking high doses of these nutrients.
College Station, TexasAges 18–45 - NCT06493084RecruitingPhase 1
Testing LAE102 in healthy and overweight adults
This study tests a new medicine called LAE102 in two groups: healthy volunteers and people who are overweight or obese. The goal is to see if it is safe and how the body processes it.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT06493968Recruiting
Medications to reduce blood loss during C-section hysterectomy for PAS
This trial tests if giving a special medication during surgery can help reduce blood loss in women with a condition called PAS (where the placenta grows too deeply into the uterus) who are having a C-section and their uterus removed. It may make the surgery safer.
CairoAges 20–40 - NCT06495684Recruiting
A brain stimulation study for adults with autism
This trial tests whether mild brain stimulation (transcranial direct current stimulation or tDCS) over multiple sessions can improve thinking, behavior, and brain activity in adults with autism. It may help researchers learn if this safe, noninvasive treatment can support better daily functioning.
Albuquerque, New MexicoAges 18–35 - NCT06496191Recruiting
Fecal transplant for alcohol use in cirrhotics
This trial tests whether a fecal microbiota transplant (FMT) can help people with alcohol-related cirrhosis who are still drinking. It aims to see if FMT can reduce alcohol cravings and improve liver health.
New Delhi, National Capital Territory of DelhiAges 18–70 - NCT06496412Recruiting
Fecal transplant for brain health in type 1 diabetes
This trial tests whether transplanting healthy bacteria into your gut can improve memory and thinking skills in people with long-term type 1 diabetes. If you have had type 1 diabetes for 10 years or more, this study may help find a new way to protect your brain.
Changsha, HunanAges 18–60 - NCT06498063Recruiting
Glucagon and kidney effects in healthy males
This trial tests how the hormone glucagon affects kidney function in healthy men. It may help researchers understand how glucagon works in the body.
CopenhagenAges 20–60 - NCT06499857RecruitingPhase 3
Semaglutide for atrial fibrillation and weight loss
This study tests whether a weekly injection of semaglutide (the same drug in Wegovy and Ozempic) can help people with atrial fibrillation lose weight and improve their heart condition. It's for people with AF who also have obesity, and may or may not plan to have a heart procedure called catheter ablation.
Phoenix, ArizonaAges 18–75 - NCT06502834RecruitingPhase 1
Testing a probiotic supplement for overweight people
This trial studies a supplement called D. piger to see if it's safe and how it affects alcohol breakdown in overweight adults with insulin resistance. You would take the supplement daily for 4 weeks.
AmsterdamAges 18–70 - NCT06502964RecruitingPhase 2
ALTO-101 study for schizophrenia cognitive symptoms
This study tests an experimental medication called ALTO-101 for people with schizophrenia who also have cognitive impairment (memory or thinking problems). It aims to see if the drug can improve these symptoms while you continue your current antipsychotic treatment.
Garden Grove, CaliforniaAges 21–55 - NCT06503016RecruitingPhase 3
Phosphocreatine for medical emergency team patients
This study tests if a medicine called phosphocreatine helps people in the hospital who have a serious heart or lung emergency. It aims to see if the medicine can improve recovery and prevent further complications.
MilanAges 18 years+ - NCT06505967Recruiting
Can a New NAD+ Supplement Boost Energy at the Cellular Level?
This study tests a daily supplement called Qualia NAD+ to see if it increases energy-related molecules inside your cells. You'll take the supplement at home, avoid other B3 vitamins, and use a simple finger-stick test to measure your levels.
Carlsbad, CaliforniaAges 40–65 - NCT06507488Recruiting
Daphnetin Capsule for Mild Cognitive Issues From Blood Vessels
This trial tests a capsule called daphnetin for people with mild thinking and memory problems linked to blood vessel health. The goal is to see if it helps improve or slow down these changes.
Shenyang, LiaoningAges 50–80 - NCT06507657RecruitingEarly Phase 1
Empagliflozin for heart health in older adults
This study tests whether a medication called empagliflozin (a diabetes drug) can improve heart function in older adults with high blood pressure and obesity who are at risk for heart failure but do not have it yet. You would take the pill daily and have heart ultrasounds to check your heart's health.
Minneapolis, MinnesotaAges 60 years+ - NCT06508983RecruitingPhase 3
SG301 for multiple myeloma returning after treatment
This trial tests a new drug called SG301 added to standard treatments (pomalidomide and dexamethasone) for people with multiple myeloma that came back or got worse after prior therapy. It may help if you have tried lenalidomide and a proteasome inhibitor but your cancer is still active.
Beijing, Beijing MunicipalityAges 18–75 - NCT06510322RecruitingEarly Phase 1
Sildenafil for LVAD support
This trial tests whether sildenafil (the drug in Viagra) can help reduce blood vessel changes in people with a left ventricular assist device (LVAD). It aims to improve heart-pump function and overall health.
The Bronx, New YorkAges 18 years+ - NCT06511063RecruitingPhase 2
Antiviral trial for treating long covid symptoms
This study tests whether antiviral drugs (Truvada and Selzentry) can help people with long COVID. You may qualify if you have had long COVID symptoms for at least 6 months, including fatigue and post-exertional malaise.
New York, New YorkAges 18 years+ - NCT06512441Recruiting
Vitamin B6 for inflammatory bowel disease
This study tests whether vitamin B6 can help treat inflammatory bowel disease (IBD). It may offer a simple, low-cost option to support your current treatment.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06512584RecruitingPhase 3
Study of PJ009 for short bowel syndrome patients needing IV nutrition
This trial tests a new medicine called PJ009 for people with short bowel syndrome who need intravenous (IV) nutrition support. It aims to help reduce the need for IV nutrition. To join, you must have been dependent on IV nutrition for at least six months and be on a stable schedule.
Beijing, Beijing MunicipalityAges 14 years+
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,962 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.